期刊文献+

消化系统恶性肿瘤合并静脉血栓栓塞患者的临床特点及预后分析 被引量:14

Clinical characteristics and prognosis of patients with malignant tumor of digestive system combined with venous thromboembolism
原文传递
导出
摘要 目的探讨消化系统恶性肿瘤合并静脉血栓栓塞(VTE)患者的临床特点及预后。方法对2003年1月至2013年4月我院住院的77例消化系统恶性肿瘤合并VTE患者的临床资料进行回顾性分析,分析其发病情况、临床特点及预后。结果77例患者中男57例、女20例,≥65岁组50例、〈65岁组27例,平均年龄(68.7±12.4)岁;其中腺癌60例(77.9%),有病理组织分化结果者47例(61.0%);77例患者中,肺血栓栓塞症(PTE)组和单纯下肢深静脉血栓(DVT)组分别有26例(33.8%)和51例(66.2%)。所有患者中最常见症状为呼吸困难和肢体肿胀或疼痛,自诊断消化系统恶性肿瘤后1、3、6、9、12及12个月以上VTE的发生率分别为24.7%(19/77)、13.0%(10/77)、19.5%(15/77)、5.2%(4/77)、5.2%(4/77)、32.5%(25/77)。截至2013年4月,共有42例(54.5%)患者死亡,其中73.8%(31/42)死于消化系统恶性肿瘤,11.9%(5/42)死于PTE,14.3%(6/42)死于其他原因。诊断VTE后1、3、6、9、12及12个月以上的病死率分别为20.8%(16/77)、6.5%(5/77)、13.0%(10/77)、5.2%(4/77)、2.6%(2/77)、6.5%(5/77)。≥65岁组和〈65岁组在诊断肿瘤后第1、3、6、9、12及12个月以上的VTE发生率差异无统计学意义(Fisher精确概率P=0.309);而在诊断vTE后第1、3、6、9、12及12个月以上的病死率差异亦无统计学意义(Fisher精确概率P=0.357),两组的中位生存时间差异无统计学意义(x2=0.290,P=0.591)。结论消化道腺癌、晚期消化道恶性肿瘤和病理组织分化程度较差(中、低分化)、化疗和手术后的消化道恶性肿瘤患者发生VTE的风险较高,且多发生于诊断后3~6个月内;死亡事件多发生于VTE诊断后1年内。 Objective To explore the clinical characteristics and prognosis of patients with malignant tumor of digestive system combined with venous thromboembolism(VTE). Methods The clinical data of 77 patients admitted in Beijing Hospital from January 2003 to April 2013 with digestive system malignant tumor complicated with VTE were retrospectively analyzed. The incidence, clinical features and prognosis of the patients with digestive system cancer were analyzed. Results Among 77 patients,57 cases of male and 20 cases of female were involved, with an average age of ( 68.7 ± 12.4 ) years, including 60 cases ( 77.9 % ) of adenocarcinoma. The pathological results showed that differentiated tumors accounted for 61.0% (47/77). Among the 77 patients, pulmonary thromboembolism (PTE) accounted for 33.8 % ( 26 cases) and deep vein thrombosis(DVT)in the low extremities accounted for 66.2 % (51 cases). Among all the patients, the most common symptoms were dyspnea and swelling or pain in the extremities. The incidence of VTE was 24.7% (19/77),13. 0%(10/77),19.5%(15/77),5.2%(4/77),5.2%(4/77),32.5% (25/77) at 1,3,6,9,12,〉 12 months after diagnosis of digestive system malignancies, respectively. By April 2013, the 54.5 % (42/77) patients died,among which 73.8% (31/42)died of digestive system malignancies, 11.9% (5/42)died of PTE, 14. 3 %(6/42)died of other causes. The mortality rates at 1,3,6,9,12, 〉 12 months after the diagnosis ofVTE were 20. 8% (16/77), 6.5% (5/77), 13.0% (10/77), 5.2% (4/77), 2.6% (2/77), 6.5% (5/77), respectively. The difference in VTE incidence between the group aged ≥65 years and group aged 〈65 years at 1,3,6,9 and 12 months after the diagnosis of tumors was not statistically significant(P = 0. 309). The differences in mortality(P= 0. 857) and in the median survival time(x2 = 0. 290, P = 0. 591) between the two groups were not statistically significant at 1,3,6,9 and 12 months after the diagnosis of VTE. Conclusions The risks for VTE are high in patients with digestive tract malignant tumor, advanced malignant tumor, poor histologic grade(poorly or moderately differentiation), and chemotherapy or surgery, which mostly occurs within 3-6 months after diagnosis. Most deaths occur within the 1st year after the diagnosis of VTE.
作者 谭政 许小毛 杨菁菁 杨鹤 乔力松 方保民 Tan Zheng Xu Xiaomao Yang Jingjing Yang He Qiao Lisong Fang Baoming(Department of Respiratory and Critical Care Medicine, Beijing Hospital, National Center of Gerontology, Beijing 100 730, China)
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2017年第10期1075-1079,共5页 Chinese Journal of Geriatrics
基金 基金项目:国家精准医学研究课题(2016YFC0905602) 国家“十二五”科技支撑课题(2011BA111B17)
关键词 肿瘤 静脉血栓栓塞 静脉血栓形成 Neoplasms Venous thromboembolism Venous thrombosis
  • 相关文献

参考文献6

二级参考文献57

  • 1王煜,李振华.肺栓塞相关因素与预后关系的临床分析[J].中国现代医学杂志,2007,17(8):948-950. 被引量:12
  • 2Andrea Rubboli,Cecilia Becattini,Freek WA Verheugt.Incidence, clinical impact and risk of bleeding during oral anticoagulation therapy[J].World Journal of Cardiology,2011,3(11):351-358. 被引量:3
  • 3王蓓,曹素艳,王雁,许锋.老年肿瘤患者合并静脉血栓栓塞症的临床调查[J].中华老年医学杂志,2007,26(6):426-428. 被引量:10
  • 4Idiz M,Konuralp C,Ates M.Under diagnosis of pulmonary embolism:a recurrent nightmare for surgeons.Eastern J Med 2003; 8:1-6
  • 5Wolfe TR,Hartsell SC.Pulmonary embolism:making sense of the diagnostic evaluation.Ann Emerg Med 2001; 37:504-514
  • 6Robinson GV.Pulmonary embolism in hospital practice.BMJ 2006; 332:156-160
  • 7McAlister FA,Bertsch K,Man J,Bradley J,Jacka M.Incidence of and risk factors for pulmonary complications after nonthoracic surgery.Am J Respir Crit Care Med 2005;171:514-517
  • 8Heit JA.The epidemiology of venous thromboembolism in the community:implications for prevention and management.J Thromb Thrombolysis 2006; 21:23-29
  • 9Klok FA,Mos IC,Huisman MV.Brain-type natriuretic peptide levels in the prediction of adverse outcome in patients with pulmonary embolism:a systematic review and meta-analysis.Am J Respir Crit Care Med 2008; 178:425-430
  • 10Konstantinides SV.Massive pulmonary embolism:what level of aggression? Semin Respir Crit Care Med 2008; 29:47-55

共引文献72

同被引文献68

引证文献14

二级引证文献105

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部